clotting factor


Also found in: Dictionary, Thesaurus, Legal, Financial, Encyclopedia, Wikipedia.
Related to clotting factor: hemophilia

clot·ting fac·tor

any of the various plasma components involved in the clotting process.
Synonym(s): coagulation factor

clotting factor

Coagulation factor. See Factor.

clot·ting fac·tor

(klot'ing fak'tŏr)
Any of the various plasma components involved in the clotting process.

Clotting factor

Also known as coagulation factors. Proteins in the plasma which serve to activate various parts of the blood clotting process by being transformed from inactive to active form.
Mentioned in: Coagulation Disorders

clot·ting fac·tor

(klot'ing fak'tŏr)
Any plasma components involved in clotting.
References in periodicals archive ?
It builds on previous work by Daniell using genetically modified plants to introduce a protein into the body that would teach the immune system to tolerate clotting factors that are given as a treatment for hemophilia.
Additionally, the presence of specific inhibitors, commonly targeting factor VIII, can cause clotting factor degradation.
Infusing a crystalloid solution (normal saline or lactated Ringer's solution) or stored packed red blood cells without clotting factors into a hemorrhaging patient will dilute the clotting factors and can actually make the patient more coagulopathic.
In its bite, the tiger keelback delivers slow-acting salivary toxins, which disable a clotting factor in the blood of its victims.
Several patients continued to use less clotting factor after combination therapy stopped.
By all accounts, this represents a dramatic reduction in the amount of reimbursement that provides for blood clotting factor and a few ancillary supplies.
In 2001, Medicare's outpatient expenditures for blood clotting factor used to treat the estimated 1,100 beneficiaries with hemophilia totaled about $105 million, or more than 2 percent of total Medicare spending on outpatient drugs.
This project will determine whether blood clotting factor homologues are expressed in fiber type-specific muscle exposed to the atrophy of simulated microgravity.
Gene therapy appears to partially correct hemophilia in dogs while avoiding an immune reaction that can destroy the life-saving replacement clotting factor used to treat the disease.
The genetic material included a human clotting factor and a pig protein.
The five behaviors that qualified as high-risk were, for hemophiliacs, having received clotting factor concentrations; for men, ever having had sex with another man since 1980; ever having taken street drugs by needle since 1980; ever having traded sex for money since 1980; and ever having had sex with a person who fits any of the above descriptions.
Gene delivery to the liver, where the factor IX clotting factor is naturally produced, resulted in easily measurable levels of factor IX for the duration of the study (270 days) and no detectable antibodies or other inhibitors of factor IX.